Electroacupuncture for agitation in alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether electroacupuncture (acupuncture with a gentle electric current) can help calm agitation in people with Alzheimer's disease. If you or a loved one has Alzheimer's and struggles with restlessness or aggression, this treatment might offer a drug-free option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of Alzheimer's disease.
- You experience agitated symptoms like restlessness, aggression, or yelling.
- Your Alzheimer's medications (like donepezil) have been stable for at least a month.
- If you take antipsychotics, the dose has been stable for at least a month.
- You have no conditions that make acupuncture unsafe, such as a bleeding tendency or metal allergy.
- You have not had electroacupuncture in the past 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether electroacupuncture can help with behavioral and psychological symptoms like agitation, anxiety, or sleep problems in people with Alzheimer's disease. It aims to improve daily life for patients and their caregivers.
This study tests an experimental medication, ITI-1284, to see if it can safely reduce agitation in people with Alzheimer's disease. Agitation can include restlessness, aggression, or irritability, and this drug aims to help manage those symptoms.
This study tests a non-invasive brain stimulation technique called transcranial alternating current stimulation (tACS) to see if it can improve memory and thinking in people with early Alzheimer's disease. It may offer a new way to help manage symptoms.
This trial tests a device that sends gentle electrical pulses to a nerve in the neck, which may help improve memory and thinking in people with mild to moderate Alzheimer's disease. It is for patients who have had a positive amyloid PET scan and are currently taking a stable dose of a cholinesterase inhibitor medication.
This trial tests whether acupuncture can improve symptoms in people with Alzheimer’s disease. You may qualify if you have memory and thinking changes consistent with Alzheimer’s and meet imaging and brain-scan score requirements.
This trial tests two new drugs (EXV-802 and EXV-801) to see if they can safely reduce moderate to severe agitation in people with Alzheimer's dementia. If you or a loved one has Alzheimer's and has been experiencing significant agitation for at least two weeks, this study may be an option.
Hear when a new Agitation Associated With Alzheimer's Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.